HPA Antibodies and the Distribution of Antigen and Antibodies

计划入组 6,170 人 · 首次发布于 2018 年 1 月 23 日

Phase 1, Open Label Clinical Trial to Treat Stage IV Cancer Patients With Multiple Patient-specific Mutated Cell Surface Proteins With Chimeric Antibodies

计划入组 16 人 · 首次发布于 2026 年 8 月 25 日

Clinical Trial to Treat Stage IV Cancer Patients

计划入组 12 人 · 首次发布于 2024 年 11 月 5 日

CD117xCD3 BiTE(Harbour BioMed)

Anti-CD117 antibody(Harbour BioMed)

therapeutic antibodies

ImmunoPrecise Antibodies

Canada

York Harbour Metals Inc

DISCOVERY HARBOUR RESOURCES CORP

Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Jury Awards $20.2 Million

Harbour BioMed Partners with Bristol Myers Squibb in $1.1 Billion Multi-Specific Antibody Deal

China Patent Office Upholds Harbour BioMed's Heavy Chain Antibody Patent in Legal Victory Over Biocytogen